These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8456415)

  • 61. Secondary Hodgkin's disease in polymyositis and type 1 diabetes mellitus after a long-term immunosuppressive treatment.
    Pumprla J; Galuszková D; Dusková J; Krc I
    Acta Univ Palacki Olomuc Fac Med; 1992; 133():87-9. PubMed ID: 1344608
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Immunotherapy in type 1 (insulin-dependent) diabetes].
    Galluzzo A
    Recenti Prog Med; 1984 Oct; 75(10):936-43. PubMed ID: 6083588
    [No Abstract]   [Full Text] [Related]  

  • 63. Type I diabetes mellitus: a chronic autoimmune disease?
    Rabinowe SL; Eisenbarth GS
    Pediatr Clin North Am; 1984 Jun; 31(3):531-43. PubMed ID: 6203091
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunosuppressive therapy in newly diagnosed diabetic children (comparison between two different strategies).
    Pocecco M; Marinoni S; Tonini G; Tedesco F
    J Endocrinol Invest; 1989; 12(8 Suppl 3):143-4. PubMed ID: 2809092
    [No Abstract]   [Full Text] [Related]  

  • 65. Immunopathogenesis and immunotherapy of type 1 diabetes.
    Wilson K; Eisenbarth GS
    Annu Rev Med; 1990; 41():497-508. PubMed ID: 2184747
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Manifestations and early course of type I diabetes mellitus--a decisive period from the viewpoint of controlling the further development of the disease].
    Vondra K; Merhaut T; Voborská M; Zamrazil V
    Vnitr Lek; 1992 Mar; 38(3):281-8. PubMed ID: 1595221
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The immune response to islets in experimental diabetes and insulin-dependent diabetes mellitus.
    Wegmann DR
    Curr Opin Immunol; 1996 Dec; 8(6):860-4. PubMed ID: 8994867
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunotherapy of type I diabetes mellitus.
    Eisenbarth GS
    Ann Intern Med; 1985 Jun; 102(6):846-8. PubMed ID: 3888026
    [No Abstract]   [Full Text] [Related]  

  • 69. [Is a gene therapy for diabetic syndromes foreseeable?].
    Assan R; Clauser E; Larger E
    Diabete Metab; 1994; 20(2 Pt 2):240-50. PubMed ID: 8001711
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Editorial Comment on type 1 diabetes and antigen-specific immunotherapy.
    Lernmark Å; Larsson HE
    J Intern Med; 2011 Aug; 270(2):132-5. PubMed ID: 21668820
    [No Abstract]   [Full Text] [Related]  

  • 71. Immunointervention in type 1 (insulin-dependent) diabetes mellitus.
    Keymeulen B; Somers G
    Acta Clin Belg; 1993; 48(2):86-95. PubMed ID: 8392249
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Immunosuppressive therapy in type 1 diabetes: update].
    Pozzilli P
    Recenti Prog Med; 1987 Nov; 78(11):514-6. PubMed ID: 3324237
    [No Abstract]   [Full Text] [Related]  

  • 73. Immunoglobulins in children with autoimmune diabetes mellitus.
    Heinze E
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S99-102. PubMed ID: 8828955
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Does the current knowledge on the pathogenesis of type 1 diabetes justify immunotherapeutic intervention?].
    Pozzilli P; Signore A; Andreani D
    Recenti Prog Med; 1986 May; 77(5):245-8. PubMed ID: 3526461
    [No Abstract]   [Full Text] [Related]  

  • 75. Autoimmune manipulation aids juvenile diabetes management.
    Hosp Pract (Off Ed); 1982 Sep; 17(9):49. PubMed ID: 6809586
    [No Abstract]   [Full Text] [Related]  

  • 76. [Immunosuppression in juvenile diabetes mellitus? Critical viewpoint on the treatment with cyclosporin A with consideration of the differential etiology].
    Teuber J; Usadel KH
    Fortschr Med; 1985 Jul; 103(27-28):707-13. PubMed ID: 4029865
    [No Abstract]   [Full Text] [Related]  

  • 77. Clinical review 17: Immunotherapy of type I diabetes mellitus.
    Marks JB; Skyler JS
    J Clin Endocrinol Metab; 1991 Jan; 72(1):3-9. PubMed ID: 1986025
    [No Abstract]   [Full Text] [Related]  

  • 78. [Immunological changes in insulin-dependent diabetes mellitus].
    Orsoni G; Nanni Costa A; Lazzari E; Bonomini V
    Minerva Endocrinol; 1986; 11(2):119-23. PubMed ID: 3785116
    [No Abstract]   [Full Text] [Related]  

  • 79. Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease.
    Stiller CR; Dupre J; Gent M; Heinrichs D; Jenner MR; Keown PA; Laupacis A; Martell R; Rodger NW; Wolfe BM
    J Pediatr; 1987 Dec; 111(6 Pt 2):1069-72. PubMed ID: 3316581
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The role of inhibitors of the complement activation system in the pathogenesis and therapy of insulin-dependent diabetes mellitus (review)].
    Aleksandrovskiĭ IaA
    Vopr Med Khim; 1988; 34(3):7-15. PubMed ID: 3047972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.